- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Complaint about Novartis tweets for press releases. PMCPA found the matter outwith the scope of the Code; no breach. No appeal and…
Dr Falk admitted Code breaches after a Salofalk-focused video was accessible without access controls on the NHS Alliance website and later appeared…
PMCPA case AUTH/2895/11/16 (Director v Boehringer Ingelheim) concerning clinical trial disclosure for Giotrif. Outcome: No breach; matter was outwith the scope of…
Invokana website patient/public pages were deemed promotional (weight loss/BP claims) and lacked general-public info. HP safety section omitted Fournier’s gangrene, making it…
An oncologist complained about a joint AstraZeneca/MSD ovarian cancer advisory board. Most allegations were not upheld, but taking identifiable photos of HCPs…
Complaint alleged Bayer-commissioned ‘Guidelines in Practice’ videos were disguised promotion for Xarelto. Panel found sponsorship and PI links were clear; no breach…
Anonymous UK health professional complained Avamys banner ad on Pulse made the generic name illegible. Panel found breaches of Clauses 4.3 and…
Complaint alleged a third-party email linked GSK-sponsored COPD therapy reviews to “client product/therapy priorities”. Panel and Appeal Board had concerns about the…
Employee alleged an ECR Vienna ‘round table’ was really a dinner to gain favour and raised concerns about ‘grey areas’ culture and…
Complaint alleged Neupro online prescribing info was out of date and omitted rhabdomyolysis. Panel found the page was an internal test URL…
Complaint alleged a senior exec’s LinkedIn post (and UK staff ‘likes’) promoted an unlicensed COVID-19 vaccine to the public. Appeal Board found…
A UK employee accidentally ‘liked’ a global Menarini LinkedIn post about positive early data for an investigational AML compound. Panel said this…
Novartis-funded third‑party “medical education” videos were ruled promotional for unlicensed inclisiran, lacked clear sponsorship disclosure and certification, and breached multiple Code clauses…
Complaint alleged GSK promoted unlicensed products to the public via LinkedIn posts about Phase 3 RSV and Covid-19 antibody trials. Panel ruled…
Complaint about Lundbeck’s UK corporate website linking to global pages and alleged lack of reapproval. Panel found no promotion/public access breach, but…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.